Press Release Stockholm, Sweden, January 3, 2022 Immunicum to Participate in Upcoming Investor and Industry Conferences in January Immunicum AB ("Immunicum" publ; IMMU.ST), a biopharmaceutical
21.12.2021 - Press Release Stockholm, Sweden, December 21, 2021 Immunicum Publishes Year-End Letter by CEO and Announces Upcoming Shareholder Event to Present Pipeline Outlook Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical .
Press ReleaseStockholm, Sweden, November 22, 2021Immunicum Publishes DCP-001 Mechanism of Action in the Journal CellsImmunicum ABas part of the Special Issue Allogeneic Cell Cancer Immunotherapies.About
Investegate announcements from Immunicum AB, Immunicum to Present Data Update on Phase II ADVANCE II at Annual American Society of Hematology Meeting (ASH)